Cargando…
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
Treatments for alopecia areata (AA) have traditionally been prescribed off-label, and there has been no universal agreement on how to best manage the condition. Baricitinib is the first oral selective Janus kinase (JAK) inhibitor approved for the treatment of adults with severe AA. As a better under...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689337/ https://www.ncbi.nlm.nih.gov/pubmed/37833617 http://dx.doi.org/10.1007/s13555-023-01044-5 |